Bristol-Myers Squibb Aktie
WKN: 850501 / ISIN: US1101221083
|
30.10.2025 12:28:26
|
Bristol-Myers Squibb Co. Q3 Profit Increases, Beats Estimates
(RTTNews) - Bristol-Myers Squibb Co. (BMY) released earnings for its third quarter that Increased from last year and beat the Street estimates.
The company's earnings came in at $2.201 billion, or $1.08 per share. This compares with $1.211 billion, or $0.60 per share, last year.
Excluding items, Bristol-Myers Squibb Co. reported adjusted earnings of $3.318 billion or $1.63 per share for the period.
Analysts on average had expected the company to earn $1.52 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 2.8% to $12.222 billion from $11.892 billion last year.
Bristol-Myers Squibb Co. earnings at a glance (GAAP) :
-Earnings: $2.201 Bln. vs. $1.211 Bln. last year. -EPS: $1.08 vs. $0.60 last year. -Revenue: $12.222 Bln vs. $11.892 Bln last year.
-Guidance: Full year EPS guidance: $6.40 - $6.60 Full year revenue guidance: $47.5 - $48.0 Bln
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bristol-Myers Squibb Co.mehr Nachrichten
Analysen zu Bristol-Myers Squibb Co.mehr Analysen
Aktien in diesem Artikel
| Bristol-Myers Squibb Co. | 39,59 | -1,07% |
|